Cargando…
How do I implement an outpatient program for the administration of convalescent plasma for COVID‐19?
Convalescent plasma, collected from donors who have recovered from a pathogen of interest, has been used to treat infectious diseases, particularly in times of outbreak, when alternative therapies were unavailable. The COVID‐19 pandemic revived interest in the use of convalescent plasma. Large obser...
Autores principales: | Bloch, Evan M., Tobian, Aaron A. R., Shoham, Shmuel, Hanley, Daniel F., Gniadek, Thomas J., Cachay, Edward R., Meisenberg, Barry R., Kafka, Kimberly, Marshall, Christi, Heath, Sonya L., Shenoy, Aarthi, Paxton, James H., Levine, Adam, Forthal, Donald, Fukuta, Yuriko, Huaman, Moises A., Ziman, Alyssa, Adamski, Jill, Gerber, Jonathan, Cruser, Daniel, Kassaye, Seble G., Mosnaim, Giselle S., Patel, Bela, Metcalf, Ryan A., Anjan, Shweta, Reisler, Ronald B., Yarava, Anusha, Lane, Karen, McBee, Nichol, Gawad, Amy, Raval, Jay S., Zand, Martin, Abinante, Matthew, Broderick, Patrick B., Casadevall, Arturo, Sullivan, David, Gebo, Kelly A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086144/ https://www.ncbi.nlm.nih.gov/pubmed/35352362 http://dx.doi.org/10.1111/trf.16871 |
Ejemplares similares
-
Early Outpatient Treatment for Covid-19 with Convalescent Plasma
por: Sullivan, David J., et al.
Publicado: (2022) -
Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma
por: Sullivan, David J., et al.
Publicado: (2021) -
Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA: a prospective cohort study
por: Zhu, Xianming, et al.
Publicado: (2023) -
Symptom Duration and Resolution With Early Outpatient Treatment of Convalescent Plasma for Coronavirus Disease 2019: A Randomized Trial
por: Baksh, Sheriza N, et al.
Publicado: (2023) -
Randomized controlled trial transfusing convalescent plasma as post-exposure prophylaxis against SARS-CoV-2 infection
por: Shoham, Shmuel, et al.
Publicado: (2021)